Neuropharmacologic Agents for Neurologic Conditions



Chemical Structure 30.1
Levodopa



A310120_1_En_30_Fig2_HTML.jpg


Chemical Structure 30.2
Benzatropine


A310120_1_En_30_Fig3_HTML.jpg


Chemical Structure 30.3
Cyclophosphamide


A310120_1_En_30_Fig4_HTML.jpg


Chemical Structure 30.4
Riluzole


A310120_1_En_30_Fig5_HTML.jpg


Chemical Structure 30.5
Azathioprine





References



1.

Dierdorf SF, Walton JS. Rare and coexisting diseases. In: Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, editors. Clinical anesthesia. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 622–43.


2.

Kivela JE, Sprung J, Southorn PA, Watson JC, Weingarten TN. Anesthetic management of patients with Huntington disease. Anesth Analg. 2010;110(2):515.PubMedCrossRef


3.

Only gold members can continue reading. Log In or Register to continue

Related posts:

Antihypertensives, Diuretics, and Antidysrhythmics Benzodiazepines and Muscle Relaxants Hormones Part 2: Insulin and Other Glucose-Controlling Medications Anticoagulant Drugs New Vistas in Anesthetics, IV Induction Agents Central Nervous System Stimulants

Stay updated, free articles. Join our Telegram channel
Tags:
Sep 18, 2016 | Posted by in ANESTHESIA | Comments Off on Neuropharmacologic Agents for Neurologic Conditions

Full access? Get Clinical Tree
Get Clinical Tree app for offline access